BioCentury
ARTICLE | Clinical News

Velusetrag: Phase II data

June 29, 2015 7:00 AM UTC

The double-blind, 3-way crossover Phase II Study 0093 trial in 34 patients with diabetic or idiopathic gastroparesis showed that once-daily oral velusetrag for 1 week reduced gastric emptying half-tim...